Fed. Circ. Knocks Down $1.7B Humira Patent Verdict
The Federal Circuit overturned a record $1.67 billion patent verdict Wednesday, negating a Texas jury's finding that Abbott Laboratories' arthritis drug Humira infringed a patent held by a Johnson & Johnson...To view the full article, register now.
Already a subscriber? Click here to view full article